296 related articles for article (PubMed ID: 8839956)
1. Neuroleptic malignant syndrome and risperidone: a case report.
Bonwick RJ; Hopwood MJ; Morris PL
Aust N Z J Psychiatry; 1996 Jun; 30(3):419-21. PubMed ID: 8839956
[TBL] [Abstract][Full Text] [Related]
2. Case study. Risperidone-Induced neuroleptic malignant syndrome in an adolescent.
Robb AS; Chang W; Lee HK; Cook MS
J Child Adolesc Psychopharmacol; 2000; 10(4):327-30. PubMed ID: 11191694
[TBL] [Abstract][Full Text] [Related]
3. High-dose vitamin E plus vitamin B6 treatment of risperidone-related neuroleptic malignant syndrome.
Dursun SM; Oluboka OJ; Devarajan S; Kutcher SP
J Psychopharmacol; 1998; 12(2):220-1. PubMed ID: 9694035
[TBL] [Abstract][Full Text] [Related]
4. Atypical neuroleptic malignant syndrome associated with risperidone treatment.
Newman M; Adityanjee ; Jampala C
Am J Psychiatry; 1997 Oct; 154(10):1475. PubMed ID: 9326841
[No Abstract] [Full Text] [Related]
5. Novel antipsychotics and the neuroleptic malignant syndrome: a review and critique.
Hasan S; Buckley P
Am J Psychiatry; 1998 Aug; 155(8):1113-6. PubMed ID: 9699705
[TBL] [Abstract][Full Text] [Related]
6. Neuroleptic malignant syndrome associated with risperidone long-acting injection: a case report.
Yamashita T; Fujii Y; Misawa F
J Clin Psychopharmacol; 2013 Feb; 33(1):127-9. PubMed ID: 23288234
[No Abstract] [Full Text] [Related]
7. [Case report: Neuroleptic malignant syndrome and diagnostic difficulties].
Khouri C; Planès S; Logerot S; Villier C; Mallaret M
Encephale; 2016 Jun; 42(3):277-80. PubMed ID: 26923996
[TBL] [Abstract][Full Text] [Related]
8. Neuroleptic Malignant Syndrome After Early Administration of Risperidone Long-Acting Injection.
Mitchell BG; McMahon BC; Mitchell CW
Prim Care Companion CNS Disord; 2017 Nov; 19(6):. PubMed ID: 29195036
[No Abstract] [Full Text] [Related]
9. Neuroleptic malignant syndrome due to three atypical antipsychotics in a child.
Chungh DS; Kim BN; Cho SC
J Psychopharmacol; 2005 Jul; 19(4):422-5. PubMed ID: 15982999
[TBL] [Abstract][Full Text] [Related]
10. Lamotrigine-induced neuroleptic malignant syndrome under risperidone treatment: a case report.
Motomura E; Tanii H; Usami A; Ohoyama K; Nakagawa M; Okada M
J Neuropsychiatry Clin Neurosci; 2012; 24(2):E38-9. PubMed ID: 22772697
[No Abstract] [Full Text] [Related]
11. Neuroleptic malignant syndrome associated with risperidone in a male with early-onset schizophrenia.
Mané A; Baeza I; Morer A; Lázaro ML; Bernardo M
J Child Adolesc Psychopharmacol; 2005 Dec; 15(6):844-5. PubMed ID: 16379503
[No Abstract] [Full Text] [Related]
12. Neuroleptic malignant syndrome and catatonia. A report of three cases.
Raja M; Altavista MC; Cavallari S; Lubich L
Eur Arch Psychiatry Clin Neurosci; 1994; 243(6):299-303. PubMed ID: 7913834
[TBL] [Abstract][Full Text] [Related]
13. Risperidone-induced neuroleptic malignant syndrome: a case report and review.
Meterissian GB
Can J Psychiatry; 1996 Feb; 41(1):52-4. PubMed ID: 8919425
[TBL] [Abstract][Full Text] [Related]
14. Neuroleptic malignant syndrome associated with use of risperidone, ritonavir, and indinavir: a case report.
Lee SI; Klesmer J; Hirsch BE
Psychosomatics; 2000; 41(5):453-4. PubMed ID: 11015640
[No Abstract] [Full Text] [Related]
15. Neuroleptic malignant syndrome caused by combination of risperidone and lithium in a patient with multiple medical comorbidities.
Kosehasanogullari SG; Akdede B; Akvardar Y; Akan M; Tunca Z
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1147-8. PubMed ID: 17513032
[No Abstract] [Full Text] [Related]
16. Risk for definite neuroleptic malignant syndrome. A prospective study in 223 consecutive in-patients.
Hermesh H; Aizenberg D; Weizman A; Lapidot M; Mayor C; Munitz H
Br J Psychiatry; 1992 Aug; 161():254-7. PubMed ID: 1355693
[TBL] [Abstract][Full Text] [Related]
17. [Rhabdomyolysis in neuroleptic therapy: an abortive malignant neuroleptic syndrome?].
Peschel O; Kurtz G; Müller-Felber W; Modell S
Nervenarzt; 1994 Oct; 65(10):718-21. PubMed ID: 7808573
[TBL] [Abstract][Full Text] [Related]
18. Encephalopathy with combined lithium-risperidone administration.
Boora K; Xu J; Hyatt J
Acta Psychiatr Scand; 2008 May; 117(5):394-5; discussion 396. PubMed ID: 18331580
[TBL] [Abstract][Full Text] [Related]
19. Neuroleptic malignant syndrome associated with risperidone and olanzapine in first-episode schizophrenia.
Aboraya A; Schumacher J; Abdalla E; LePage J; McGhee M; Butcher D; Griffin H; Shahda M
W V Med J; 2002; 98(2):63-5. PubMed ID: 12048741
[TBL] [Abstract][Full Text] [Related]
20. [Neuroleptic malignant syndrome. Case reports].
Berardi D; Troia M; Veronesi L; Ferrari G
Minerva Psichiatr; 1994 Dec; 35(4):199-219. PubMed ID: 7861943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
